Abstract
The angiotensin-converting enzyme 2 (ACE2) receptor has been proved for SARS-CoV-2 cell entry after auxiliary cellular protease priming by transmembrane protease serine 2 (TMPRSS2), but the co-effect of this molecular mechanism was unknown. Here, single-cell sequencing was performed with human conjunctiva and the results have shown that ACE2 and TMPRSS2 were highly co-expressed in the goblet cells with genes involved in immunity process. This identification of conjunctival cell types which are permissive to virus entry would help to understand the process by which SARS-CoV-2 infection was established. These finding might be suggestive for COVID-19 control and protection.
| Original language | English |
|---|---|
| Article number | 108501 |
| Number of pages | 4 |
| Journal | Experimental Eye Research |
| Volume | 205 |
| DOIs | |
| Publication status | Published - Apr 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
User-Defined Keywords
- SARS-CoV-2
- Conjunctival goblet cell
- ACE2
- TMPRSS2
Fingerprint
Dive into the research topics of 'High expression of SARS-CoV-2 entry factors in human conjunctival goblet cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver